Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.
Department of Medical Disciplines, Faculty of Medicine and Pharmacy of Oradea, University of Oradea, 410073 Oradea, Romania.
Biomed Pharmacother. 2022 Aug;152:113238. doi: 10.1016/j.biopha.2022.113238. Epub 2022 Jun 7.
Oxidative stress is a complex biological process characterized by the excessive production of reactive oxygen species (ROS) that act as destroyers of the REDOX balance in the body and, implicitly, inducing oxidative damage. All the metabolisms are impaired in oxidative stress and even nucleic acid balance is influenced. ROS will promote structural changes of the tissues and organs due to interaction with proteins and phospholipids. The constellation of the cardiovascular risk factors (CVRFs) will usually develop in subjects with predisposition to cardiac disorders. Oxidative stress is usually related with hypertension (HTN), diabetes mellitus (DM), obesity and cardiovascular diseases (CVDs) like coronary artery disease (CAD), cardiomyopathy or heart failure (HF), that can develop in subjects with the above-mentioned diseases. Elements describing the complex relationship between CVD and oxidative stress should be properly explored and described because prevention may be the optimal approach. Our paper aims to expose in detail the complex physiopathology of oxidative stress in CVD occurrence and novelties regarding the phenomenon. Biomarkers assessing oxidative stress or therapy targeting specific pathways represent a major progress that actually change the outcome of subjects with CVD. New antioxidants therapy specific for each CVD represents a captivating and interesting future perspective with tremendous benefits on subject's outcome.
氧化应激是一种复杂的生物学过程,其特征是活性氧(ROS)的过度产生,ROS 作为体内氧化还原平衡的破坏者,从而导致氧化损伤。氧化应激会损害所有代谢过程,甚至会影响核酸平衡。ROS 会通过与蛋白质和磷脂的相互作用,促进组织和器官的结构变化。心血管危险因素(CVRFs)的组合通常会在易患心脏疾病的人群中发展。氧化应激通常与高血压(HTN)、糖尿病(DM)、肥胖和心血管疾病(CVDs)有关,如冠状动脉疾病(CAD)、心肌病或心力衰竭(HF),这些疾病可能会在上述疾病患者中发展。应该详细探讨和描述描述 CVD 和氧化应激之间复杂关系的元素,因为预防可能是最佳方法。我们的论文旨在详细阐述 CVD 发生过程中氧化应激的复杂病理生理学以及该现象的最新进展。评估氧化应激的生物标志物或针对特定途径的治疗方法代表了重大进展,实际上改变了 CVD 患者的结局。针对每种 CVD 的特定抗氧化剂治疗代表了一个吸引人且有趣的未来前景,对患者的结局有巨大的益处。